Goldman Sachs Recommends 23 Defensive Stocks Amid AI Spending Slowdown
Current overview (not historical)
Goldman Sachs has issued a short list of 23 defensive stocks, urging investors to move into healthcare and consumer staples as AI capital spending slows. The firm estimates that AI accounts for roughly half of S&P 500 earnings growth, yet the Cyclicals‑vs‑Defensives pair has underperformed by about 6% in the last two weeks. Goldman’s base case projects that falling interest rates in 2027 will boost household spending, further supporting defensive sectors. The recommendation reflects a shift away from AI‑heavy growth names toward more resilient, consumer‑focused companies in a changing macro environment.
Written with AI from the reporting · updated 10/20/2026
Expand the detailed fact route and sources
Story route
A station-by-station route from the first public evidence onward; every station carries its own evidence and uncertainty.
- 1Unclassified fact stationOct 19, 00:00recorded Oct 20, 19:51single source
Goldman Sachs names 23 defensive stocks for AI trade concern
Read original source ↗ BeInCryptoReplay this moment in the explorerEvidence & revisions · 1 source records
- Subject:
- Goldman Sachs
- Action:
- released defensive stock shortlist
- Object:
- health care and consumer staples stocks
- Occurred (fact side):
- Oct 19, 00:00
- Published (valid side):
- Oct 20, 19:00
- First seen (known side):
- Oct 20, 19:51
Fact stationSingle source · one-sided claimCopy may have been revised later; time replay is bounded. Layer labels group reading only, not causation between layers.
Uncertainty marks flag where to check the sources; they are not proven causation.
Report timeline
Explore every side through dated source reports.
- BeInCryptoRelated fact: single sourceGoldman Sachs recommends defensive stocks as AI trade concerns grow
Report first recorded Oct 20, 19:51
Goldman Sachs has identified 23 defensive stocks in healthcare and consumer staples with low volatility and high free cash flow yields, steering investors away from the AI trade. The recommendation comes as analysts cite rising interest rates pressuring AI earnings expectations, with S&P 500 earnings growth projected to slow from 29% in 2026 to 18% in 2027. The list includes companies such as Merck, CVS Health, and Tyson Foods, which offers the highest free cash flow yield at 11% over the trailing four quarters.
Read original source ↗
Event discussion
Reader opinions are hosted on GitHub Discussions; posting requires a GitHub account. Comments are not verified facts.